Should I Buy UPC? UPC 2026 Analysis

Should You Buy Universe Pharmaceuticals Inc (UPC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

4.160

1 Day change

-3.26%

52 Week Range

18.000

Analysis Updated At

2026/01/26

Universe Pharmaceuticals Inc (UPC) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are neutral to slightly bearish, there are no significant trading trends, no recent news or positive catalysts, and no proprietary trading signals. Given the lack of clear bullish indicators or strong growth potential, holding off on this investment is recommended for now.

Technical Analysis

The MACD histogram is -0.0206, below 0, and negatively expanding, indicating bearish momentum. The RSI_6 is at 42.512, in the neutral zone, suggesting no clear signal. Moving averages are converging, and the pre-market price of 4.0791 is near the key support level of 4.065, with resistance at 4.294. Overall, the technical indicators do not suggest a strong buy signal.

Options Data

Positive Catalysts

NULL identified. No recent news or significant trading trends from hedge funds or insiders.

Neutral/Negative Catalysts

Bearish MACD, lack of significant trading trends, and no recent news or catalysts.

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target changes provided.

Analyst Rating

Wall Street analysts forecast UPC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UPC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 4.300

Low

Averages

High